These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32395382)

  • 41. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
    Alves WEFM; Bonatelli M; Dufloth R; Kerr LM; Carrara GFA; da Costa RFA; Scapulatempo-Neto C; Tiezzi D; da Costa Vieira RA; Pinheiro C
    BMC Cancer; 2019 Dec; 19(1):1173. PubMed ID: 31795962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    Sannachi L; Gangeh M; Tadayyon H; Sadeghi-Naini A; Gandhi S; Wright FC; Slodkowska E; Curpen B; Tran W; Czarnota GJ
    PLoS One; 2018; 13(1):e0189634. PubMed ID: 29298305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
    Luangdilok S; Samarnthai N; Korphaisarn K
    J Breast Cancer; 2014 Dec; 17(4):376-85. PubMed ID: 25548587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients.
    Kim KI; Lee KH; Kim TR; Chun YS; Lee TH; Park HK
    J Breast Cancer; 2014 Mar; 17(1):40-6. PubMed ID: 24744796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype.
    Fukuda T; Horii R; Gomi N; Miyagi Y; Takahashi S; Ito Y; Akiyama F; Ohno S; Iwase T
    Springerplus; 2016; 5():152. PubMed ID: 27026849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer.
    Sasada S; Kimura Y; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
    Anticancer Res; 2020 Jun; 40(6):3395-3400. PubMed ID: 32487636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erratum: An Erratum to Correct Typographical Errors.
    Ann Rehabil Med; 2016 Dec; 40(6):1151. PubMed ID: 28119849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erratum: An Erratum to Correct Typographical Errors.
    Ann Rehabil Med; 2016 Oct; 40(5):959. PubMed ID: 27847729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum: ERRATUM.
    Urol Ann; 2011 May; 3(2):61. PubMed ID: 21747592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erratum: ERRATUM.
    Indian J Anaesth; 2011 Mar; 55(2):121. PubMed ID: 21712866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.
    Jin X; Jiang YZ; Chen S; Yu KD; Ma D; Sun W; Shao ZM; Di GH
    BMC Cancer; 2016 Aug; 16():606. PubMed ID: 27495967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype.
    Candelaria RP; Bassett RL; Symmans WF; Ramineni M; Moulder SL; Kuerer HM; Thompson AM; Yang WT
    Oncologist; 2017 Apr; 22(4):394-401. PubMed ID: 28314842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erratum: From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer [Erratum].
    Int J Nanomedicine; 2019; 14():335. PubMed ID: 30643410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy.
    Teixidó C; Karachaliou N; González-Cao M; Morales-Espinosa D; Rosell R
    Cancer Biol Med; 2015 Sep; 12(3):259. PubMed ID: 26487971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Factors related with pathological complete response of neoadjuvant chemotherapy in primary breast cancer].
    Cheng YJ; Ye JM; Xu L; Zhao JX; Duan XN; Liu YH
    Zhonghua Wai Ke Za Zhi; 2013 Apr; 51(4):339-43. PubMed ID: 23895756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Feasibility of predicting pathological evaluation by ultrasonic evaluation in initial stage of neoadjuvant chemotherapy for primary breast cancer].
    Qi M; Li JF; Xie YT; Lu AP; Liu YQ; Lin BY; Ouyang T
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):511-4. PubMed ID: 20367959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erratum: Expression of Tim-3 in breast cancer tissue promotes tumor progression.
    Cheng S; Han F; Xu Y; Qu T; Ju Y
    Int J Clin Exp Pathol; 2021; 14(7):855. PubMed ID: 34367417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
    Cuello-López J; Fidalgo-Zapata A; López-Agudelo L; Vásquez-Trespalacios E
    PLoS One; 2018; 13(11):e0207224. PubMed ID: 30427884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.